A new trading day began on Tuesday, with Prothena Corporation plc (NASDAQ: PRTA) stock price down -3.32% from the previous day of trading, before settling in for the closing price of $10.84. PRTA’s price has ranged from $10.00 to $25.42 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 4692.68%. Meanwhile, its annual earnings per share averaged -58.69%. With a float of $42.50 million, this company’s outstanding shares have now reached $53.83 million.
Let’s determine the extent of company efficiency that accounts for 163 employees. In terms of profitability, gross margin is 56.79%, operating margin of -114.36%, and the pretax margin is -95.39%.
Prothena Corporation plc (PRTA) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Prothena Corporation plc is 21.05%, while institutional ownership is 98.11%.
Prothena Corporation plc (PRTA) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.87 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -58.69% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -15.39% during the next five years compared to -3.15% drop over the previous five years of trading.
Prothena Corporation plc (NASDAQ: PRTA) Trading Performance Indicators
Here are Prothena Corporation plc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 10.01. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.17.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.30, a number that is poised to hit -0.97 in the next quarter and is forecasted to reach -3.53 in one year’s time.
Technical Analysis of Prothena Corporation plc (PRTA)
Looking closely at Prothena Corporation plc (NASDAQ: PRTA), its last 5-days average volume was 0.66 million, which is a jump from its year-to-date volume of 0.43 million. As of the previous 9 days, the stock’s Stochastic %D was 14.61%. Additionally, its Average True Range was 0.93.
During the past 100 days, Prothena Corporation plc’s (PRTA) raw stochastic average was set at 6.00%, which indicates a significant decrease from 12.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 58.95% in the past 14 days, which was lower than the 85.80% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $13.84, while its 200-day Moving Average is $17.13. However, in the short run, Prothena Corporation plc’s stock first resistance to watch stands at $11.20. Second resistance stands at $11.93. The third major resistance level sits at $12.35. If the price goes on to break the first support level at $10.05, it is likely to go to the next support level at $9.63. Now, if the price goes above the second support level, the third support stands at $8.90.
Prothena Corporation plc (NASDAQ: PRTA) Key Stats
With a market capitalization of 564.11 million, the company has a total of 53,827K Shares Outstanding. Currently, annual sales are 135,160 K while annual income is -122,310 K. The company’s previous quarter sales were 2,120 K while its latest quarter income was -57,960 K.
